Canavan Disease News and Research

RSS
Rowan University, Bamboo Therapeutics partner to combat Canavan disease

Rowan University, Bamboo Therapeutics partner to combat Canavan disease

UC Davis researchers settle long-standing controversy surrounding Canavan disease

UC Davis researchers settle long-standing controversy surrounding Canavan disease

RowanSOM researcher awarded NINDS grant to develop stem cell-based therapy for Canavan disease

RowanSOM researcher awarded NINDS grant to develop stem cell-based therapy for Canavan disease

Narrow therapeutic window for Canavan disease

Narrow therapeutic window for Canavan disease

Novel virus-based gene therapy holds promise for Canavan disease

Novel virus-based gene therapy holds promise for Canavan disease

AAV-based gene therapy cocktail may help extend lives of children with Canavan disease

AAV-based gene therapy cocktail may help extend lives of children with Canavan disease

FDA lifts hold, allows Geron to proceed with Phase I clinical trial of GRNOPC1 in spinal cord injury

FDA lifts hold, allows Geron to proceed with Phase I clinical trial of GRNOPC1 in spinal cord injury

Gene patenting policies affect patient access to testing for disease-causing genes: Study

Gene patenting policies affect patient access to testing for disease-causing genes: Study

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.